An extended course of Paxlovid appears to help some patients with long COVID, according to a case series by UC San Francisco researchers that suggests this treatment option holds promise for some of ...
Who is eligible for a COVID vaccine? While early FDA guidelines restricted COVID vaccinations to older adults or those with preexisting conditions, the California Department of Public Health (CDPH) ...
SAN FRANCISCO -- The popular COVID treatment, Paxlovid, does not significantly lower the risk of "long COVID" for people who are vaccinated. In a new study from UCSF, researchers found that patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results